Knott David M Jr »

Agios Pharmaceuticals shares owned by Knott David M Jr

Quarter-by-quarter ownership of Agios Pharmaceuticals (AGIO) shares owned by Knott David M Jr from 13F filings

Historical chart of Knott David M Jr investment in Agios Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Agios Pharmaceuticals held by Knott David M Jr consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Agios Pharmaceuticals by Knott David M Jr

Quarter filed Position value Share count Share price at filing
2025-12-31 $490k 18k 27.22

More positions owned by Knott David M Jr

Calumet Common (CLMT)
Apollo Global Management Common (APO)
Alphabet Inc-Cl C Common (GOOG)
Syndax Pharmaceutical Common (SNDX)
Xeris Biopharma Holdings Common (XERS)
Travere Therapeutics Common (TVTX)
Bridgebio Pharma Common (BBIO)
Protagonist Therapeutics Common (PTGX)
JPMorgan Chase & Co. Common (JPM)
Janus Henderson AAA CLO ETF Common (JAAA)
Viridian Therapeutics Common (VRDN)
Catalyst Pharmaceuticals Common (CPRX)
Cogent Biosciences Common (COGT)
Mersana Therapeutics Common (MRSN)
Arcus Biosciences Common (RCUS)

View all positions for Knott David M Jr

Top funds holding Agios Pharmaceuticals

Vanguard Group
BlackRock
Farallon Capital Management
State Street Corporation
Susquehanna International
Erste Asset Management GmbH
Wellington Management Company
Armistice Capital
Jane Street
Geode Capital Management
Bnp Paribas Investment Partners
MPM Oncology Impact Management
Frazier Life Sciences Management
Jennifer Ranahan
TCG Crossover Management

View all funds holding Agios Pharmaceuticals